TG Therapeutics | TGTX - L'Utile Ante Imposte





L'Utile Ante Imposte Cambiamento Data
AbbVie USD 7.61B 2.04B 2026-06
Alaunos Therapeutics USD -7.84M 633K 2023-12
Amgen USD 2.08B 570M 2026-03
Ardelyx USD -37.6M 37.2M 2026-03
Arrowhead Research USD -178.9M 41.34M 2026-06
Bayer EUR 321M 2.67B 2026-06
Biogen USD 647.3M 269.6M 2026-06
Corcept Therapeutics USD -44.72M 54.62M 2026-03
Curis USD -24.2M 43.56M 2026-03
Gilead Sciences USD -7.53B 10.11B 2026-06
J&J USD 8.66B 839M 2026-06
Karyopharm Therapeutics USD -22.39M 17.51M 2026-03
Novartis USD 4.27B 430M 2026-06
Novavax USD 17.9M 220.94M 2025-12
PTC Therapeutics USD -2.46M 136.62M 2026-03
Puma Biotechnology USD 20.61M 24.76M 2024-09
Regeneron Pharmaceuticals USD 1.53B 696.6M 2026-06
Roche Holding CHF 11.17B 6.38B 2026-06
TG Therapeutics USD 10.23M 10.13M 2026-06
Verastem USD -36.59M 3.68M 2026-03
Vertex Pharmaceuticals USD 1.39B 138.9M 2026-06